Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 17, 2018
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
Journal: The Journal of rheumatology
Published: November 05, 2013
Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study.
Journal: The Journal of rheumatology
Published: April 03, 2013
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.
Journal: The Journal of rheumatology
Published: June 19, 2012
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
Journal: Arthritis and rheumatism
Published: June 08, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026